BFG
RMD icon

Bleakley Financial Group’s ResMed RMD Stock Holding History

Bleakley Financial Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,213
Closed -$506K – 887
2024
Q4 		$506K Sell
2,213
-21
-0.9% -$5.06K 0.02% 618
2024
Q3 		$545K Buy
2,234
+78
+4% +$17.4K 0.02% 582
2024
Q2 		$413K Buy
2,156
+96
+5% +$19.5K 0.01% 667
2024
Q1 		$408K Sell
2,060
-20
-1% -$3.67K 0.01% 674
2023
Q4 		$358K Buy
2,080
+625
+43% +$96K 0.01% 684
2023
Q3 		$215K Sell
1,455
-687
-32% -$124K 0.01% 783
2023
Q2 		$468K Sell
2,142
-3
-0.1% -$669 0.01% 605
2023
Q1 		$470K Sell
2,145
-221
-9% -$47.9K 0.02% 588
2022
Q4 		$492K Buy
+2,366
New +$520K 0.02% 561

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Bleakley Financial Group's RMD Position: Q1 2025 in Review

Bleakley Financial Group sold out of ResMed (RMD) in Q1 2025, closing a stake of 2,213 shares — an estimated $506K sold.

Bleakley Financial Group first reported a position in RMD in Q4 2022 and held it in 9 quarters. The position peaked at $545K in Q3 2024. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Bleakley Financial Group reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Bleakley Financial Group sold 2,213 ResMed shares in Q1 2025, an estimated $506K.
  • Bleakley Financial Group first reported a position in ResMed in Q4 2022 and held it in 9 quarters.
  • Bleakley Financial Group's ResMed position peaked at $545K in Q3 2024.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Bleakley Financial Group's 13F filing for Q1 2025, filed 1 May 2025.